How did Novartis AG's revenue change from 2023 to 2024?

Novartis AG revenue grew from $47.8B in 2023 to $50.3B in 2024, a change of 5.3%.

Was 2024 Novartis AG's best revenue year?

No. Novartis AG's highest recorded revenue year was 2025 at $54.5B. In 2024, Novartis AG reported $50.3B.

What was Novartis AG's highest ever annual revenue?

Novartis AG's highest ever annual revenue was $54.5B recorded in fiscal year 2025.

Novartis AG

PharmaceuticalsFounded 1996

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Explore Novartis AG

Core profile pages, annual revenue records, and related research hubs for this company.

Novartis AG

PharmaceuticalsFounded 1996

Reviewed by Swet Parvadiya

Last reviewed: June 2026

Annual Revenue

Novartis AG Revenue in 2024

Q: What was Novartis AG's revenue in 2024?

Novartis AG reported $50.3B in revenue for fiscal year 2024. This represents a +5.3% change compared to 2023. Revenue climbed 5.3% to $50.3 billion in FY2024, the first full year Novartis operated as a pure-play innovative medicines company after the October 2023 Sandoz spin-off.

FY2024 Revenue

$50.3B

▲ 5.3% vs FY2023 ($47.8B)

Source: Annual report / company filing

Novartis AG reported $50.3B in revenue for fiscal year 2024. This represents a growth of 5.3% compared to the 2023 figure of $47.8B. In 2025, revenue increased to $54.5B.

Revenue climbed 5.3% to $50.3 billion in FY2024, the first full year Novartis operated as a pure-play innovative medicines company after the October 2023 Sandoz spin-off.

Revenue by Year

FY2025 FY2024 FY2023

Novartis AG Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2025	$54.5B	$14.0B	+8.3%
FY2024	$50.3B	—	+5.3%
FY2023	$47.8B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2023: $47.8B

Next year →

FY2025: $54.5B

Explore Novartis AG

Core profile pages, annual revenue records, and related research hubs for this company.